Sanofi
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sanofi's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1% to $46,033,000,000. Profit margin reached 12%. Total operating expenses were $23,942,000,000.

Profit Margin

Sanofi (NASDAQ:SNY): Profit margin
2014 31.99B 4.39B 13.72%
2015 34.86B 4.28B 12.3%
2016 34.69B 4.70B 13.57%
2017 36.22B 3.89B 10.75%
2018 35.67B 4.30B 12.07%
2019 37.63B 2.75B 7.32%
2020 37.36B 12.29B 32.9%
2021 39.17B 6.22B 15.89%
2022 45.38B 8.37B 18.44%
2023 46.03B 5.4B 11.73%

SNY Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
46.03B45.38B39.17B37.36B37.63B35.67B36.22B34.69B34.86B31.99B
Cost of revenue
14.23B13.69B12.25B12.15B11.97B11.43B11.44B10.70B10.91B10.23B
Gross profit
31.79B31.69B26.92B25.21B25.65B24.24B24.77B23.99B23.94B21.76B
Operating exp.
Research and development
6.72B6.70B5.69B5.52B6.02B5.89B5.56B5.17B5.08B4.66B
Selling and marketing
0009.39B9.88B9.85B10.05B9.47B9.38B9.10B
Total operating expenses
23.94B19.81B17.77B17.31B18.47B17.98B17.39B16.46B16.80B16.24B
Operating income
7.87B10.65B8.12B8.08B3.05B4.67B12.00B6.53B12.71B12.62B
Other income (expenses), net
-722M-1.22B-1.01B24M-4.12B-1.51B-188M-995M-403M-458M
Income before tax
7.15B10.42B7.79B13.80B2.75B4.40B5.61B5.67B5.22B5.60B
Income tax expense
1.60B2.00B1.55B1.81B121M481M1.72B1.32B709M1.21B
Net income
5.4B8.37B6.22B12.29B2.75B4.30B3.89B4.70B4.28B4.39B
Earnings per share
Basic EPS
4.316.694.979.812.331.733.081.833.383.25
Diluted EPS
4.36.664.959.762.311.723.071.823.343.21
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source